Funder
Grant-in-Aid for Intractable Renal Diseases Research, Research on rare and intractable diseases, Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan
Alexion Pharmaceuticals (US)
Asahi Kasei Pharma Corporation
Astellas Pharma
Baxter International
Bristol-Myers Squibb
Chugai Pharmaceutical
Daiichi-Sankyo
Kyowa Hakko Kirin
Merck Sharp and Dohme
Mitsubishi Tanabe pharma
Mochida Pharmaceutical Company
Novartis Pharmaceuticals Corporation
Otsuka Pharmaceutical
Pfizer Japan
Sanwa Kagaku Kenkyusho
Dainippon Sumitomo Pharma
Takeda Pharmaceutical Company
Teijin Pharma
Torii Pharmaceutical
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis. 2010;69:798–806.
2. Kang Y, Park JS, Ha YJ, Kang MI, Park HJ, Lee SW, et al. Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Schönlein purpura. J Korean Med Sci. 2014;29:198–203.
3. Hong S, Ahn SM, Lim DH, Ghang B, Yang WS, Lee SK, et al. Late-onset IgA vasculitis in adult patients exhibits distinct clinical characteristics and outcomes. Clin Exp Rheumatol. 2016;34(3 Suppl 97):S77–83.
4. Kiryluk K, Moldoveanu Z, Sanders JT, Eison TM, Suzuki H, Julian BA, et al. Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis. Kidney Int. 2011;80:79–87.
5. Gardner-Medwin JM, Dolezalva P, Cummins C, Southwood TR. Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002;360:1197–202.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献